Company intelligence
Parse Biosciences
Scalable Single Cell Sequencing Without the Instrument
Biotechnology Research
Seattle, US
51–200 employees
Founded 2018
4 public signals
About Parse Biosciences
Parse Biosciences is a global life sciences company whose mission is to accelerate progress in human health and scientific research. Empowering researchers to perform single cell sequencing with unprecedented scale and ease, our pioneering approach is enabling groundbreaking discoveries in cancer treatment, tissue repair, stem cell therapy, kidney and liver disease, brain development, and the immune system.
Verified activity
Signals from Parse Biosciences
4 published signals
Research & Knowledge
Parse Biosciences published a new case study showing that researchers at UMC Hamburg-Eppendorf profiled 777,000+ immune cells from AML patients before and after stem cell transplant using Evercode scRNA-seq to identify two biomarkers, MDGA1 and ADGRG1, linked to graft-versus-host and graft-versus-leukemia.
Reported by Parse Biosciences
Presence & Recognition
Parse Biosciences hosted a single cell webinar featuring speaker Ellen Kuwana, MS, sharing practical strategies for identifying new funding sources and crafting proposals.
Reported by Parse Biosciences
Presence & Recognition
Parse Biosciences is hosting the fifth and final webinar in the single cell series Putting the data to work, featuring Joseph Pearson and Ruth Stoney from QIAGEN Digital Insights on September 16th.
Reported by Parse Biosciences